Sponsored content by Castle Biosciences, Inc. Dr. Guenther has not been compensated in connection with this article; Dr. Guenther receives compensation for his participation on the Speaker’s bureau for Castle Biosciences.
J. Michael Guenther, M.D., Surgical Oncologist, St. Elizabeth Physicians, Edgewood, Kentucky
Advertisement
Articles by J. Michael Guenther, M.D., Surgical Oncologist, St. Elizabeth Physicians, Edgewood, Kentucky
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Mezigdomide Plus Kd in R/R Myeloma
2
Dostarlimab Achieves Sustained Clinical Complete Responses in dMMR/MSI-H Rectal Cancer
3
Dive Into Key Data and Presentations From EHA 2026
4
Access, Sequencing Considerations Remain Key Focal Points for CAR T-Cell Therapy in R/R Myeloma
5